title: Characterisation of an in vivo Pig-a gene mutation assay for use in regulatory toxicology studies.
abstract: Integration of in vivo genotoxicity testing into standard toxicology studies presents multiple advantages as it reduces animal use and costs, accelerates data generation and provides concurrent data that are useful for interpreting results. The in vivo Pig-a assay is a mammalian gene mutation assay that utilises peripheral blood and thus has a high integration potential. Although inter-laboratory reproducibility has been well demonstrated, further characterisation is required for this assay. In this study, we evaluated intra-laboratory reproducibility of the in vivo Pig-a gene mutation assay (MutaFlow® kit) in rats through the conduct of an assay characterisation prior to subsequent use in Good Laboratory Practices (GLP) toxicology studies. To evaluate intra-laboratory reproducibility, intra-assay and inter-assay variability, ruggedness, robustness and blood storage stability were assessed. These assessments were performed using blood obtained from male Sprague-Dawley rats exposed to 0, 20 or 40mg/kg/day N-ethyl-N-nitrosourea via oral gavage for three consecutive days. Blood was collected from these rats on multiple occasions from Day 29 to Day 71 and samples were analysed for Pig-a mutation using the rat MutaFlow kit. Frequencies of reticulocytes (RET), mutant phenotype erythrocytes (RBC(CD59-)) and mutant phenotype RET (RET(CD59-)) were determined. Overall, the proportion of RET and frequencies of RBC(CD59-) and of RET(CD59-) were consistent throughout the different assessments. The assay demonstrated acceptable intra-run and inter-run variability with coefficients of variation of ≤4.8 and 20.6%, respectively. The method was shown to be independent of the analyst performing the assay and unaffected by small changes in assay conditions. Comparable results were obtained from freshly collected samples and samples refrigerated for up to 4 days. Although technically challenging, the rat Pig-a gene mutation assay using a high-throughput automated method was shown to be reliable. The different assay parameters evaluated during the conduct of this study yielded acceptable results. Thus, the method was considered suitable for use in GLP toxicology studies.
authors: ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada jgodin@itrlab.com.
authors: Jessica
authors: J
authors: Godin-Ethier
authors: ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada.
authors: Francis
authors: F
authors: Leroux
authors: ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada.
authors: Nan
authors: N
authors: Wang
authors: ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada.
authors: Sybil
authors: S
authors: Thébaud
authors: ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada.
authors: Farida
authors: F
authors: Merah
authors: ITR Laboratories Canada, Inc., 19601 Clark Graham, Baie d'Urfé (Montreal), Quebec H9X 3T1, Canada.
authors: Andrew
authors: A
authors: Nelson
mesh_terms: D000818:Animals; D004252:DNA Mutational Analysis; D005038:Ethylnitrosourea / Q000633:toxicity; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D009152:Mutagenicity Tests / Q000379:methods; D009153:Mutagens / Q000633:toxicity; D009154:Mutation; D017207:Rats, Sprague-Dawley; D012156:Reticulocytes / Q000187:drug effects
chemical_list: D008565:Membrane Proteins; D009153:Mutagens; C080086:phosphatidylinositol glycan-class A protein; D005038:Ethylnitrosourea